These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Genetic diversity of Chlamydia pecorum strains in wild koala locations across Australia and the implications for a recombinant C. pecorum major outer membrane protein based vaccine. Kollipara A, Polkinghorne A, Wan C, Kanyoka P, Hanger J, Loader J, Callaghan J, Bell A, Ellis W, Fitzgibbon S, Melzer A, Beagley K, Timms P. Vet Microbiol; 2013 Dec 27; 167(3-4):513-22. PubMed ID: 24012135 [Abstract] [Full Text] [Related]
6. Prevalence and clinical significance of koala retrovirus in two South Australian koala (Phascolarctos cinereus) populations. Fabijan J, Miller D, Olagoke O, Woolford L, Boardman W, Timms P, Polkinghorne A, Simmons G, Hemmatzadeh F, Trott DJ, Speight KN. J Med Microbiol; 2019 Jul 27; 68(7):1072-1080. PubMed ID: 31162024 [Abstract] [Full Text] [Related]
9. Humoral immune responses in koalas (Phascolarctos cinereus) either naturally infected with Chlamydia pecorum or following administration of a recombinant chlamydial major outer membrane protein vaccine. Khan SA, Polkinghorne A, Waugh C, Hanger J, Loader J, Beagley K, Timms P. Vaccine; 2016 Feb 03; 34(6):775-82. PubMed ID: 26747718 [Abstract] [Full Text] [Related]
11. Interleukin 17A is an immune marker for chlamydial disease severity and pathogenesis in the koala (Phascolarctos cinereus). Mathew M, Waugh C, Beagley KW, Timms P, Polkinghorne A. Dev Comp Immunol; 2014 Oct 03; 46(2):423-9. PubMed ID: 24915607 [Abstract] [Full Text] [Related]
12. Treatment of Chlamydia-associated ocular disease via a recombinant protein based vaccine in the koala (Phascolarctos cinereus). Waugh C, Austin R, Polkinghorne A, Timms P. Biologicals; 2016 Nov 03; 44(6):588-590. PubMed ID: 27707559 [Abstract] [Full Text] [Related]
13. Identification, characterisation and expression analysis of natural killer receptor genes in Chlamydia pecorum infected koalas (Phascolarctos cinereus). Morris KM, Mathew M, Waugh C, Ujvari B, Timms P, Polkinghorne A, Belov K. BMC Genomics; 2015 Oct 15; 16():796. PubMed ID: 26471184 [Abstract] [Full Text] [Related]
15. Infection with koala retrovirus subgroup B (KoRV-B), but not KoRV-A, is associated with chlamydial disease in free-ranging koalas (Phascolarctos cinereus). Waugh CA, Hanger J, Loader J, King A, Hobbs M, Johnson R, Timms P. Sci Rep; 2017 Mar 09; 7(1):134. PubMed ID: 28273935 [Abstract] [Full Text] [Related]
16. Characterisation of CD4 T cells in healthy and diseased koalas (Phascolarctos cinereus) using cell-type-specific monoclonal antibodies. Mangar C, Armitage CW, Timms P, Corcoran LM, Beagley KW. Dev Comp Immunol; 2016 Jul 09; 60():80-90. PubMed ID: 26905635 [Abstract] [Full Text] [Related]
17. Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: evaluation of immunity and pathology. Kollipara A, George C, Hanger J, Loader J, Polkinghorne A, Beagley K, Timms P. Vaccine; 2012 Feb 27; 30(10):1875-85. PubMed ID: 22230583 [Abstract] [Full Text] [Related]
18. A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus). Waugh C, Khan SA, Carver S, Hanger J, Loader J, Polkinghorne A, Beagley K, Timms P. PLoS One; 2016 Feb 27; 11(1):e0146934. PubMed ID: 26756624 [Abstract] [Full Text] [Related]